Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on April 28, 2025

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth Quarter 2024 Financial Highlights ( …

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple presentations …

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will …

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced new preclinical data in collaboration with Moderna on an mRNA …

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a …

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically relevant targets, including many targets …

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025
Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumors FMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key limitations of non-covalent approaches Addresses a defined …

Helping Kids Brush Their Teeth: HelloNation Spotlights Dr. Andrew Beuttenmuller of Watertown Pediatric Dentistry And How He Gets Kids Excited About Oral Health
WATERTOWN, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- Making dental hygiene fun is a crucial step in helping children build positive associations with oral care. This is a perspective emphasized by Dr. Andrew Beuttenmuller of Watertown Pediatric Dentistry, …

Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)
New York, April 28, 2025 (GLOBE NEWSWIRE) -- Within the weight loss supplement industry, Supra Keto BHB + ACV Gummies are revolutionary, employing two of the best fat-burning compounds: Beta-Hydroxybutyrate (BHB) and Apple Cider Vinegar (ACV). The goal of …

Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime
Glasgow, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- Testosterone levels are the driving force behind a man’s strength, muscle growth, energy, and overall vitality. But unfortunately, testosterone production naturally peaks during young adulthood— …
![Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?](/images/pressrelease-small.png)
Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?
Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- Sugar Defender's Secret Formula Finally Revealed – Know How It Supports Healthy Blood Sugar Naturally? With our increasingly busy world, it has never been more important to balance blood sugar. Blood …

Milestone Consensus Statement on AI Issued by Power Users As Part of the Health IT End-Users Alliance
Chicago, April 28, 2025 (GLOBE NEWSWIRE) -- Since taking office in January, the Trump-Vance Administration has signaled a new government approach to artificial intelligence (AI), emphasizing a “forward leaning” and “pro innovation” approach to the …

New Study Reveals Homeless Sex Offender Crisis State by State
Austin, TX, April 28, 2025 (GLOBE NEWSWIRE) -- A new report from the Cicero Institute finds that sex offenders make up a significant proportion of the unsheltered homeless population across many U.S. states. In eight states, over half of the unsheltered …

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation* NDV-01 showed promising clinical activity in BCG-naïve and BCG-unresponsive patients, …

SARMs Cardarine GW 50156: Cardarine For Sale, Cardarine Cycle, Cardarine Benefits, Cardarine Dosage, Cardarine Before and After, Cardarine Effects, Cardarine Side Effects, Buy, (C-Dine By CrazyBulk)
New York City, April 28, 2025 (GLOBE NEWSWIRE) -- “C-DINE 501516 is an all natural, safe, and legal CARDARINE GW501516 alternative that delivers natural ingredients to help fire-up your metabolism and transition your body into a natural fat-burning state!” …